Axon Enterprise, Inc $AXON Position Raised by Silver Grove Financial Group Inc.

Silver Grove Financial Group Inc. increased its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 21,088.0% during the third quarter, according to its most recent filing with the SEC. The fund owned 5,297 shares of the biotechnology company’s stock after buying an additional 5,272 shares during the quarter. Axon Enterprise accounts for approximately 1.0% of Silver Grove Financial Group Inc.’s portfolio, making the stock its 14th largest holding. Silver Grove Financial Group Inc.’s holdings in Axon Enterprise were worth $2,238,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Keybank National Association OH grew its position in shares of Axon Enterprise by 68,460.5% during the 3rd quarter. Keybank National Association OH now owns 698,632 shares of the biotechnology company’s stock valued at $295,186,000 after acquiring an additional 697,613 shares during the period. Cornerstone Wealth Management LLC increased its stake in shares of Axon Enterprise by 7,632.7% during the 3rd quarter. Cornerstone Wealth Management LLC now owns 57,454 shares of the biotechnology company’s stock worth $24,275,000 after purchasing an additional 56,711 shares during the last quarter. Csenge Advisory Group raised its holdings in shares of Axon Enterprise by 10,535.0% in the 3rd quarter. Csenge Advisory Group now owns 122,515 shares of the biotechnology company’s stock worth $51,765,000 after purchasing an additional 121,363 shares during the period. New York Life Investment Management LLC raised its holdings in shares of Axon Enterprise by 4,560.7% in the 3rd quarter. New York Life Investment Management LLC now owns 633,710 shares of the biotechnology company’s stock worth $267,755,000 after purchasing an additional 620,113 shares during the period. Finally, 71 West Capital Partners raised its holdings in shares of Axon Enterprise by 1,266.0% in the 3rd quarter. 71 West Capital Partners now owns 19,042 shares of the biotechnology company’s stock worth $8,046,000 after purchasing an additional 17,648 shares during the period. Institutional investors own 79.08% of the company’s stock.

More Axon Enterprise News

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon is investing $1.2 billion for a 37% stake in drone maker Skydio and will become its U.S. public-safety distributor. The deal could broaden Axon’s public-safety technology offering, though its scale also brings investment and execution risks. Axon invests in Skydio
• Positive Sentiment: West Fargo police plan to replace Flock technology with Axon’s system, including new AI features—an example of continued adoption by public-safety customers. West Fargo police adoption
• Positive Sentiment: Despite lowering its price target, Barclays retained an “overweight” rating at $507; Northland reportedly still sees a $540 target after the stock’s steep fall from its August high. These views suggest some analysts see substantial recovery potential, though targets are not guarantees. Northland target outlook
• Neutral Sentiment: A short-interest report lists 0 shares short, despite describing a large increase. The figure appears inconsistent and does not provide a reliable indication of short-selling pressure.
• Negative Sentiment: Axon’s third-quarter adjusted EPS of $1.72 and revenue of about $909 million fell short of estimates. Cautious guidance and roughly $130 million in federal-contract revenue shifting out of 2026 have weighed on the outlook; shares have fallen sharply since the results, while Motorola rose after its earnings beat. Axon versus Motorola after earnings
• Negative Sentiment: Law firms announced investigations into potential securities-law violations. These are allegations under investigation, not findings of wrongdoing, but may add legal and reputational uncertainty for investors. Axon securities investigation notice

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on AXON shares. Piper Sandler reissued an “overweight” rating and set a $540.00 price objective (down from $561.00) on shares of Axon Enterprise in a report on Friday, November 6th. Weiss Ratings reissued a “hold (c-)” rating on shares of Axon Enterprise in a research report on Tuesday, November 3rd. Zacks Research lowered Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 3rd. Northland Securities set a $540.00 target price on Axon Enterprise in a research note on Friday. Finally, JPMorgan Chase & Co. dropped their price target on Axon Enterprise from $755.00 to $610.00 and set an “overweight” rating on the stock in a research report on Friday, November 6th. Thirteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $612.18.

Axon Enterprise Stock Performance

NASDAQ AXON opened at $302.54 on Wednesday. The company’s 50 day moving average is $430.30 and its 200-day moving average is $472.14. Axon Enterprise, Inc has a 12-month low of $291.45 and a 12-month high of $665.07. The company has a quick ratio of 2.60, a current ratio of 3.00 and a debt-to-equity ratio of 0.76. The firm has a market cap of $24.58 billion, a P/E ratio of 96.97, a price-to-earnings-growth ratio of 5.76 and a beta of 1.48.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Thursday, November 5th. The biotechnology company reported $1.72 EPS for the quarter, missing analysts’ consensus estimates of $1.89 by ($0.17). The business had revenue of $908.55 million for the quarter, compared to analysts’ expectations of $934.33 million. Axon Enterprise had a net margin of 7.56% and a return on equity of 3.87%. The business’s quarterly revenue was up 27.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.17 earnings per share. Sell-side analysts predict that Axon Enterprise, Inc will post 2.10 earnings per share for the current year.

Insider Buying and Selling at Axon Enterprise

In other news, CEO Patrick W. Smith sold 10,000 shares of the firm’s stock in a transaction on Tuesday, September 8th. The stock was sold at an average price of $508.99, for a total value of $5,089,900.00. Following the completion of the transaction, the chief executive officer directly owned 3,118,012 shares of the company’s stock, valued at $1,587,036,927.88. This trade represents a 0.32% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 16,775 shares of the firm’s stock in a transaction on Monday, August 31st. The stock was sold at an average price of $574.43, for a total value of $9,636,063.25. Following the completion of the transaction, the president directly owned 296,974 shares of the company’s stock, valued at $170,590,774.82. The trade was a 5.35% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 37,397 shares of company stock worth $21,234,034. 4.20% of the stock is owned by insiders.

Axon Enterprise Company Profile

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.